Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways

Autor: Samuel A L Hall, Gareth S Burns, Benjamin J Mooney, Rosemary Millen, Rachel Morris, Sara Vogrin, Vijaya Sundararajan, Dilip Ratnam, Miriam T Levy, John S Lubel, Amanda J Nicoll, Simone I Strasser, William Sievert, Paul V Desmond, Meng C Ngu, Peter Angus, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A Revill, Kathy Jackson, Margaret Littlejohn, Scott Bowden, Stephen A Locarnini, Alexander J Thompson, Kumar Visvanathan

Publikováno v: The Journal of Infectious Diseases. 227:123-132

Background We evaluated the patterns of peripheral Toll-like receptor (TLR) signaling activity and the expression of TLRs and natural killer (NK) cell activation in a cohort of patients experiencing severe hepatitis flares after stopping nucleot(s)id

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96195df56d6d5554c2616e986f479876
https://doi.org/10.1093/infdis/jiac375

Hepatitis B screening before rituximab therapy: a multicentre South Australian study of adherence

Autor: Chris Karapetis, Samuel A. L. Hall, Kate Muller, Douglas Coghlan, Mohammad A. Chinnaratha, Mahsa Tantiongco, Richard J. Woodman, Abdul Shaikh, Kailin Teh, Alan Wigg

Publikováno v: Internal Medicine Journal. 48:936-943

Background International guidelines recommend screening for hepatitis B virus (HBV) infection prior to administration of rituximab, due to high risk of HBV reactivation in at-risk patients. Aims To determine: (i) adherence to the South Australian (SA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a7bc4efa84a821d07eae4b68a40d5222
https://doi.org/10.1111/imj.13740

Stopping nucleot(s)ide analogues in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.

Autor: Hall, Samuel A. L.^1,2 (AUTHOR) sammy.hall86@gmail.com, Burns, Gareth S.^1,2 (AUTHOR), Anagnostou, Despina¹ (AUTHOR), Vogrin, Sara² (AUTHOR), Sundararajan, Vijaya^2,3 (AUTHOR), Ratnam, Dilip^4,5 (AUTHOR), Levy, Miriam T.⁶ (AUTHOR), Lubel, John S.^7,8 (AUTHOR), Nicoll, Amanda J.⁹ (AUTHOR), Strasser, Simone I.^10,11 (AUTHOR), Sievert, William^4,5 (AUTHOR), Desmond, Paul V.¹ (AUTHOR), Ngu, Meng C.¹² (AUTHOR), Angus, Peter^13,14 (AUTHOR), Sinclair, Marie¹³ (AUTHOR), Meredith, Christopher¹⁵ (AUTHOR), Matthews, Gail¹⁶ (AUTHOR), Revill, Peter A.¹⁷ (AUTHOR), Jackson, Kathy¹⁷ (AUTHOR), Littlejohn, Margaret¹⁷ (AUTHOR)

Publikováno v: Alimentary Pharmacology & Therapeutics. Jul2022, Vol. 56 Issue 2, p310-320. 11p. 2 Charts, 3 Graphs.

Hepatitis B screening before rituximab therapy: a multicentre South Australian study of adherence.

Autor: Hall, Samuel A. L., Shaikh, Abdul, Teh, Kailin, Tantiongco, Mahsa, Coghlan, Douglas, Karapetis, Chris S., Chinnaratha, Mohammad A., Woodman, Richard, Muller, Kate R., Wigg, Alan J.

Publikováno v: Internal Medicine Journal; Aug2018, Vol. 48 Issue 8, p936-943, 8p, 2 Diagrams, 5 Charts